OpenLegislation

Regulation 27 Amendment of regulation 36 (conditions for manufacturer's licence)I1

United Kingdom

In regulation 36 F1—

(a)

in paragraph (4)—.

(i)

for “The requirements” substitute “Where a manufacturer’s licence relates to the manufacture or assembly of a medicinal product in, or import of a medicinal product into, Northern Ireland, the requirements”;

(ii)

for “provisions of a manufacturer’s” substitute “provisions of that”;

(b)

in paragraph (6), after “by way of wholesale dealing” insert “in Northern Ireland”.

Annotations

Textual amendments

F1

Reg. 27(a)(b) substituted for words (31.12.2020 immediately before IP completion day) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1488), reg. 1, Sch. 2 para. 17

Commencement

I1

Reg. 27 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1